Abstract
Environmental exposure to inorganic arsenic (iAs) has been shown to disturb glucose homeostasis, leading to diabetes. Previous laboratory studies have suggested several mechanisms that may underlie the diabetogenic effects of iAs exposure, including (i) inhibition of insulin signaling (leading to insulin resistance) in glucose metabolizing peripheral tissues, (ii) inhibition of insulin secretion by pancreatic β cells, and (iii) dysregulation of the methylation or expression of genes involved in maintenance of glucose or insulin metabolism and function. Published studies have also shown that acute or chronic iAs exposures may result in depletion of hepatic glycogen stores. However, effects of iAs on pathways and mechanisms that regulate glycogen metabolism in the liver have never been studied. The present study examined glycogen metabolism in primary murine hepatocytes exposed in vitro to arsenite (iAs3+) or its methylated metabolite, methylarsonite (MAs3+). The results show that 4-h exposures to iAs3+ and MAs3+ at concentrations as low as 0.5 and 0.2 µM, respectively, decreased glycogen content in insulin-stimulated hepatocytes by inhibiting insulin-dependent activation of glycogen synthase (GS) and by inducing activity of glycogen phosphorylase (GP). Further investigation revealed that both iAs3+ and MAs3+ inhibit insulin-dependent phosphorylation of protein kinase B/Akt, one of the mechanisms involved in the regulation of GS and GP by insulin. Thus, inhibition of insulin signaling (i.e., insulin resistance) is likely responsible for the dysregulation of glycogen metabolism in hepatocytes exposed to iAs3+ and MAs3+. This study provides novel information about the mechanisms by which iAs exposure impairs glucose homeostasis, pointing to hepatic metabolism of glycogen as one of the targets.
Similar content being viewed by others
References
Adeva-Andany MM, Gonzalez-Lucan M, Donapetry-Garcia C, Fernandez-Fernandez C, Ameneiros-Rodriguez E (2016) Glycogen metabolism in humans. BBA Clin 5:85–100
Agius L (2015) Role of glycogen phosphorylase in liver glycogen metabolism. Mol Aspects Med 46:34–45
Aiston S, Coghlan MP, Agius L (2003) Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis. Eur J Biochem 270:2773–2781
Albores A, Cebrian ME, Garcia-Vargas GG, Connelly JC, Price SC, Hinton RH, Bach PH, Bridges JW (1996) Enhanced arsenite-induced hepatic morphological and biochemical changes in phenobarbital-pretreated rats. Toxicol Pathol 24:172–180
Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541–6551
Bailey KA, Wu MC, Ward WO, Smeester L, Rager JE, Garcia-Vargas G, Del Razo LM, Drobna Z, Styblo M, Fry RC (2013) Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol 27:106–115
Berry LJ, Smythe DS (1959) Carbohydrate metabolism in normal and altitude-exposed mice following arsenite poisoning. Am J Physiol 197:37–40
Chung ST, Hsia DS, Chacko SK, Rodriguez LM, Haymond MW (2014) Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes. Diabetologia 58:596–603
Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453–508
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–789
Dashty M (2013) A quick look at biochemistry: carbohydrate metabolism. Clin Biochem 46:1339–1352
DePaoli-Roach AA, Vilardo PG, Kim JH, Mavila N, Vemuri B, Roach PJ (2003) Determination of mammalian glycogen synthase phosphatase activity. Methods Enzymol 366:17–34
Diaz-Villasenor A, Burns AL, Hiriart M, Cebrian ME, Ostrosky-Wegman P (2007) Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol Appl Pharmacol 225:123–133
Díaz-Villaseñor A, Sánchez-Soto MC, Cebrián ME, Ostrosky-Wegman P, Hiriart M (2006) Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol Appl Pharmacol. 214(1):30–34
Díaz-Villaseñor A, Burns AL, Salazar AM, Sordo M, Hiriart M, Cebrián ME, Ostrosky-Wegman P (2008) Arsenite reduces insulin secretion in rat pancreatic beta-cells by decreasing the calcium-dependent calpain-10 proteolysis of SNAP-25. Toxicol Appl Pharmacol. 231(3):291–299
Douillet C, Currier J, Saunders J, Bodnar WM, Matousek T, Styblo M (2013) Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. Toxicol Appl Pharmacol 267:11–15
Drobna Z, Walton FS, Paul DS, Xing W, Thomas DJ, Styblo M (2009) Metabolism of arsenic in human liver: the role of membrane transporters. Arch Toxicol 84:3–16
Fu J, Woods CG, Yehuda-Shnaidman E, Zhang Q, Wong V, Collins S, Sun G, Andersen ME, Pi J (2010) Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect 118:864–870
Huang CF, Yang CY, Chan DC, Wang CC, Huang KH, Wu CC, Tsai KS, Yang RS, Liu SH (2015) Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice. Environ Health Perspect 123:1138–1144
Hue L, Bontemps F, Hers H (1975) The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem J 152:105–114
Imazu M, Strickland WG, Chrisman TD, Exton JH (1984a) Phosphorylation and inactivation of liver glycogen synthase by liver protein kinases. J Biol Chem 259:1813–1821
Imazu M, Strickland WG, Exton JH (1984b) Multiple phosphorylation of rat-liver glycogen synthase by protein kinases. Biochim Biophys Acta 789:285–293
Kawaguchi I (1981) Studies on As2O3-induced hyperglycemia (author’s transl). Nihon Yakurigaku Zasshi 78:213–222
Klover PJ, Mooney RA (2004) Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol 36:753–758
Krssak M, Brehm A, Bernroider E, Anderwald C, Nowotny P, Dalla Man C, Cobelli C, Cline GW, Shulman GI, Waldhausl W, Roden M (2004) Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53:3048–3056
Lin HV, Accili D (2011) Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 14:9–19
Liu S, Guo X, Wu B, Yu H, Zhang X, Li M (2014) Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice. Sci Rep 4:6894
Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, Silbergeld EK, Styblo M, Tseng CH, Thayer KA, Loomis D (2012) Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120:1658–1670
Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E (2006) Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect 114:641–648
Nuttall FQ, Gannon MC (1989) An improved assay for hepatic glycogen synthase in liver extracts with emphasis on synthase R. Anal Biochem 178:311–319
Park SK, Peng Q, Bielak LF, Silver KD, Peyser PA, Mitchell BD (2016) Arsenic exposure is associated with diminished insulin sensitivity in non-diabetic Amish adults. Diabetes Metab Res Rev. 32(6):565–571
Paul DS, Harmon AW, Devesa V, ThoMAs DJ, Styblo M (2007) Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 115:734–742
Peti W, Nairn AC, Page R (2012) Structural basis for protein phosphatase 1 regulation and specificity. FEBS J 280:596–611
Reichl FX, Szinicz L, Kreppel H, Forth W (1988) Effect of arsenic on carbohydrate metabolism after single or repeated injection in guinea pigs. Arch Toxicol 62:473–475
Reichl FX, Kreppel H, Szinicz L, Fichtl B, Forth W (1991) Effect of glucose treatment on carbohydrate content in various organs in mice after acute As2O3 poisoning. Vet Hum Toxicol 33:230–235
Rines AK, Sharabi K, Tavares CD, Puigserver P (2016) Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov 15:786–804
Roach PJ, Cheng C, Huang D, Lin A, Mu J, Skurat AV, Wilson W, Zhai L (1998) Novel aspects of the regulation of glycogen storage. J Basic Clin Physiol Pharmacol 9:139–151
Rognstad R (1979) Rate-limiting steps of metabolic pathways. J Biol Chem 254:1875–1878
Ros S, Garcia-Rocha M, Dominguez J, Ferrer JC, Guinovart JJ (2009) Control of liver glycogen synthase activity and intracellular distribution by phosphorylation. J Biol Chem 284:6370–6378
Rosella G, Zajac JD, Kaczmarczyk SJ, Andrikopoulos S, Proietto J (1993) Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 7:1456–1462
Rylatt DB, Aitken A, Bilham T, Condon GD, Embi N, Cohen P (1980) Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur J Biochem 107:529–537
Saheki S, Takeda A, Shimazu T (1985) Assay of inorganic phosphate in the mild pH range, suitable for measurement of glycogen phosphorylase activity. Anal Biochem 148:277–281
Sharabi K, Tavares CD, Rines AK, Puigserver P (2015) Molecular pathophysiology of hepatic glucose production. Mol Aspects Med 46:21–33
Singh P, Dutta SR, Passi D, Bharti J (2017) Benefits of alcohol on arsenic toxicity in rats. J Clin Diagn Res 11:BF01–BF06
Spuches AM, Kruszyna HG, Rich AM, Wilcox DE (2005) Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. Inorg Chem 44:2964–2972
Srivastava AK, Pandey SK (1998) Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem 182:135–141
Stalmans W, Hers HG (1975) The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase. Eur J Biochem 54:341–350
Steffens AA, Hong GM, Bain LJ (2010) Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin. Toxicol Appl Pharmacol 250:154–161
Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in human cells. Arch Toxicol 74:289–299
Sung TC, Huang JW, Guo HR (2015) Association between arsenic exposure and diabetes: a meta-analysis. Biomed Res Int 2015:368087
Thomas JA, Schlender KK, Larner J (1968) A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25:486–499
Thomas DJ, Li J, Waters SB, Xing W, Adair BM, Drobna Z, Devesa V, Styblo M (2007) Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med (Maywood). 232:3–13
Tseng CH (2004) The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol. 197(2):67–83
Verma RJ, Vasu A, Saiyed AA (2004) Arsenic toxicity in mice and its possible amelioration. J Environ Sci (China) 16:447–453
Walton FS, Harmon AW, Paul DS, Drobna Z, Patel YM, Styblo M (2004) Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol 198:424–433
Wang ZX, Jiang CS, Liu L, Wang XH, Jin HJ, Wu Q, Chen Q (2005) The role of Akt on arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation. Cell Res 15:379–386
Wauson EM, Langan AS, Vorce RL (2002) Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicol Sci 65:211–219
Welsh GI, Wilson C, Proud CG (1996) GSK3: a SHAGGY frog story. Trends Cell Biol 6:274–279
Xue P, Hou Y, Zhang Q, Woods CG, Yarborough K, Liu H, Sun G, Andersen ME, Pi J (2011) Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: involvement of the adaptive antioxidant response. Biochem Biophys Res Commun 407:360–365
Yen YP, Tsai KS, Chen YW, Huang CF, Yang RS, Liu SH (2010) Arsenic inhibits myogenic differentiation and muscle regeneration. Environ Health Perspect 118:949–956
Zhang C, Wendel AA, Keogh MR, Harris TE, Chen J, Coleman RA (2012) Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc Natl Acad Sci U S A 109:1667–1672
Zhang C, Cooper DE, Grevengoed TJ, Li LO, Klett EL, Eaton JM, Harris TE, Coleman RA (2014) Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor. Am J Physiol Endocrinol Metab 307:E305–E315
Acknowledgements
This work was supported by Grants from the National Institute of Health (R01ES022697 and DK 056350). The authors thank Dr. Rosalind Coleman (Department of Nutrition, University of North Carolina at Chapel Hill) for her helpful suggestions regarding the methods used in this study and result interpretation.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhang, C., Fennel, E.M.J., Douillet, C. et al. Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes. Arch Toxicol 91, 3811–3821 (2017). https://doi.org/10.1007/s00204-017-2076-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-017-2076-9